SCHEMBL6072959

SCHEMBL6072959

O=C(NC1C2CN(Cc3ccccc3)CC21)N1CCc2ccccc2C1c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM3 P20309 3/20 0.50
HHAT Q5VTY9 3/20 0.49
CYP2D6 P10635 1/20 0.48
GRIN1 Q05586 1/20 0.48
GRIN2B Q13224 1/20 0.48
SIGMAR1 Q99720 1/20 0.48
TRPM8 Q7Z2W7 5/20 0.47
HDAC8 Q9BY41 1/20 0.47
CACNA1F O60840 1/20 0.46
CHRM2 P08172 1/20 0.46
CHRM4 P08173 1/20 0.46
CHRM5 P08912 1/20 0.46
CHRM1 P11229 1/20 0.46
KCNE1 P15382 1/20 0.46
KCNQ1 P51787 1/20 0.46
CACNA1D Q01668 1/20 0.46
KCNH2 Q12809 1/20 0.46
CACNA1S Q13698 1/20 0.46
CACNA1C Q13936 1/20 0.46
SCN5A Q14524 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6072947 0.87 HHAT (0.47) CHRM3HHATCYP2D6GRIN1GRIN2B
SCHEMBL6072987 0.81 CHRM3 (0.52) CHRM3HHATCYP2D6GRIN1GRIN2B
SCHEMBL6073004 0.81 CHRM3 (0.52) CHRM3HHATCYP2D6TRPM8HDAC8
SCHEMBL6073099 0.80 MCHR1 (0.43) CHRM3HHATCYP2D6SIGMAR1
SCHEMBL17117236 0.77 HHAT (0.54) HHATCYP2D6TRPM8HDAC8
SCHEMBL6072890 0.76 CHRM3 (0.61) CHRM3HHATCYP2D6GRIN1GRIN2B
SCHEMBL17117340 0.75 EPHX2 (0.58) HHATCYP2D6TRPM8HDAC8
SCHEMBL23436290 0.74 CHRM3 (0.84) CHRM3CACNA1FCHRM2CHRM4CHRM5
SCHEMBL23436318 0.74 CHRM3 (0.84) CHRM3CACNA1FCHRM2CHRM4CHRM5
SCHEMBL12153444 0.74 HHAT (0.57) CHRM3HHATCYP2D6TRPM8HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006035280-A1 3,4-DIHYDROISOQUINOLINE COMPOUNDS AS MUSCRINIC RECEPTOR ANTAGONISTS FOR THE TREATMENT OF RESPIRATORY, URINARY AND GASTROINTESTINAL DISEASES RANBAXY LABORATORIES LIMITED (IN) 2006-04-06 WO claimed
WO-2006035280-A1 3,4-DIHYDROISOQUINOLINE COMPOUNDS AS MUSCRINIC RECEPTOR ANTAGONISTS FOR THE TREATMENT OF RESPIRATORY, URINARY AND GASTROINTESTINAL DISEASES RANBAXY LABORATORIES LIMITED (IN) 2006-04-06 WO disclosed